Luzon, Alvin D.

HRN: 23-34-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/17/2023
08/24/2023
IV
54mg
Q24h
Pcap C
Waiting Final Action 
08/17/2023
AMPICILLIN 500MG (VIAL)
08/17/2023
08/24/2023
IV
360mg
Q12
Pcap C
Waiting Final Action 
08/18/2023
CEFOTAXIME 500MG (VIAL)
08/18/2023
08/24/2023
IV
120mg
Q8
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: